These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 1713295)
21. Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Sällberg M; Rudén U; Magnius LO; Norrby E; Wahren B Immunol Lett; 1991 Sep; 30(1):59-68. PubMed ID: 1720419 [TBL] [Abstract][Full Text] [Related]
22. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus. Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531 [TBL] [Abstract][Full Text] [Related]
23. Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals. Khakoo SI; Ling R; Scott I; Dodi AI; Harrison TJ; Dusheiko GM; Madrigal JA Gut; 2000 Jul; 47(1):137-43. PubMed ID: 10861276 [TBL] [Abstract][Full Text] [Related]
24. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes. Kuhröber A; Wild J; Pudollek HP; Chisari FV; Reimann J Int Immunol; 1997 Aug; 9(8):1203-12. PubMed ID: 9263018 [TBL] [Abstract][Full Text] [Related]
25. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg. Milich DR; McLachlan A; Moriarty A; Thornton GB J Immunol; 1987 Aug; 139(4):1223-31. PubMed ID: 2440947 [TBL] [Abstract][Full Text] [Related]
26. A monoclonal antibody against a hepatitis B e antigen epitope borne by six amino acids encoded by the precore region. Usuda S; Okamoto H; Ohnuma H; Tanaka T; Machida A; Miyakawa Y; Mayumi M J Virol Methods; 1997 Nov; 68(2):207-15. PubMed ID: 9389411 [TBL] [Abstract][Full Text] [Related]
27. Significance of antibody to hepatitis Be antigen (anti-HBe) in HBsAg-negative individuals. Hess G; Arnold W; Gahl GM; Vogl E; Meyer zum Büschenfelde KH Vox Sang; 1981 Feb; 40(2):95-8. PubMed ID: 7233888 [TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies specific for hepatitis B e antigen and hepatitis B core antigen. Sogut I; Hatipoglu I; Kanbak G; Basalp A Hybridoma (Larchmt); 2011 Oct; 30(5):475-9. PubMed ID: 22008076 [TBL] [Abstract][Full Text] [Related]
29. Epitope analysis of an immunodominant domain on the P1 protein of Haemophilus influenzae type b using synthetic peptides and anti-idiotypic antibodies. Proulx C; Hamel J; Chong P; Martin D; Brodeur BR Microb Pathog; 1992 Jun; 12(6):433-42. PubMed ID: 1522798 [TBL] [Abstract][Full Text] [Related]
30. Comparative immunogenicity of hepatitis B virus core and E antigens. Milich DR; McLachlan A; Stahl S; Wingfield P; Thornton GB; Hughes JL; Jones JE J Immunol; 1988 Nov; 141(10):3617-24. PubMed ID: 2460543 [TBL] [Abstract][Full Text] [Related]
31. Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid. Tordjeman M; Fontan G; Rabillon V; Martin J; Trepo C; Hoffenbach A; Mabrouk K; Sabatier JM; Van Rietschoten J; Somme G J Med Virol; 1993 Nov; 41(3):221-9. PubMed ID: 7505307 [TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus DNA in anti-HBe-positive asymptomatic carriers. Seo Y; Yoon S; Nakaji M; Yano Y; Nagano H; Ninomiya T; Hayashi Y; Kasuga M Intervirology; 2003; 46(1):43-9. PubMed ID: 12566698 [TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remission. Carman WF; Boner W; Fattovich G; Colman K; Dornan ES; Thursz M; Hadziyannis S J Infect Dis; 1997 May; 175(5):1093-100. PubMed ID: 9129071 [TBL] [Abstract][Full Text] [Related]
34. Cytotoxic T-cell responses to the nucleocapsid proteins of HBV in chronic hepatitis. Evidence that antibody modulation may cause protracted infection. Pignatelli M; Waters J; Lever A; Iwarson S; Gerety R; Thomas HC J Hepatol; 1987 Feb; 4(1):15-21. PubMed ID: 3494760 [TBL] [Abstract][Full Text] [Related]
35. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. Penna A; Chisari FV; Bertoletti A; Missale G; Fowler P; Giuberti T; Fiaccadori F; Ferrari C J Exp Med; 1991 Dec; 174(6):1565-70. PubMed ID: 1720813 [TBL] [Abstract][Full Text] [Related]
36. Cellular immune responses of peripheral blood mononuclear cells to HBV antigens during chronic and acute HBV infection. Wakita T; Kakumu S; Yoshioka K; Ishikawa T; Ito Y; Shinagawa T Digestion; 1992; 52(1):26-33. PubMed ID: 1426694 [TBL] [Abstract][Full Text] [Related]
37. Re-examination and further characterization of a monoclonal antibody to hepatitis B e antigen (anti-HBe). Stuckmann Spiezia K; Mushahwar IK J Virol Methods; 1986 Jul; 13(4):351-62. PubMed ID: 2427536 [TBL] [Abstract][Full Text] [Related]
38. Distinguishing between acute and symptomatic chronic hepatitis B virus infection. Maruyama T; Schödel F; Iino S; Koike K; Yasuda K; Peterson D; Milich DR Gastroenterology; 1994 Apr; 106(4):1006-15. PubMed ID: 7511551 [TBL] [Abstract][Full Text] [Related]
39. HBc and HBe specificity of monoclonal antibodies against complete and truncated HBc proteins from E. coli. Korec E; Gerlich WH Arch Virol Suppl; 1992; 4():119-21. PubMed ID: 1280501 [TBL] [Abstract][Full Text] [Related]